DrugPatentWatch Database Preview

Drugs in Development Information for Afuresertib

« Back to Dashboard

Summary for Afuresertib

US Patents	11
International Patents	158
US Patent Applications	52
WIPO Patent Applications	24
Japanese Patent Applications	0
Clinical Trial Progress	Phase 1 (2015-08-01)
Vendors	26

US Patents for Afuresertib

Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
Afuresertib		Inhibitors of Akt activity	GlaxoSmithKline LLC (Philadelphia, PA)
Afuresertib		Inhibitors of Akt activity	GlaxoSmithKline LLC (Philadelphia, PA)
Afuresertib		Pharmaceutical composition	GlaxoSmithKline LLC (Philadelphia, PA)
Afuresertib		Chemical compounds	GlaxoSmithKline LLC (Philadelphia, PA)
Afuresertib		Crystalline N-{(1S)-2-amino-1-[(3-fluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-m- ethyl-1H-pyrazol-5-yl)-2-thiophenecarboxamic hydrochloride	GlaxoSmithKline LLC (Philadelphia, PA)
Afuresertib		Combination of a B-Raf inhibitor: N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1- dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfo- namide and the Akt inhibitor: N-{ (1S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chIoro-4-(4-chIoro- 1 -methyl- 1 H-pyrazol-5-yl)-2-10 thiophenecarboxamide useful in the treatment of cancer	GlaxoSmithKline LLC (Wilmington, DE)
Afuresertib		Inhibitors of AkT activity	GlaxoSmithKline LLC (Wilmington, DE)

International Patents for Afuresertib

Drugname	Country	Document Number	Estimated Expiration	Related US Patent
Afuresertib	Argentina	066184	2027-02-07
Afuresertib	Australia	2008213694	2027-02-07
Afuresertib	Brazil	PI0807146	2027-02-07
Afuresertib	Canada	2678255	2027-02-07
Afuresertib	Chile	2008000348	2027-02-07
Afuresertib	China	101646427	2027-02-07
Afuresertib	Colombia	6220930	2027-02-07